+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Cluster Headache Market 2019-2025

  • PDF Icon


  • May 2020
  • Region: Global
  • Orion Market Research Private Limited
  • ID: 5129626
Global Cluster Headache Market Size, Share & Trends Analysis Report by Type (Episodic and Chronic), By Drug Type (Fast-Acting Drugs, Long-Term Drugs, and Short-Term Drugs), Forecast 2019-2025.

The global cluster headache market is anticipated to grow at a significant CAGR during the forecast period. Across the globe, the cluster headache market is mainly driven by the increasing focus of government and nongovernment organizations to increase awareness regarding cluster headache among patients with various campaigns and programs. For instance, “What’s Under the Hat” is one such campaign launched in 2015 by the European Headache Alliance (EHA) to address the issue of increasing cases of cluster headache in the European region.

The global cluster headache market is segmented on the basis of type and drug type. On the basis of type, the market is bifurcated into episodic cluster headache and chronic cluster headache. Episodic cluster headache is more common than chronic cluster headache and hence contributes a significant share to the market. Based on drug type, the market is sub-segmented into fast-acting drugs, long-term drugs, and short-term drugs. Fast-acting drugs for cluster headache is estimated to hold a prominent share in the market.

Geographically, the study of the global cluster headache market report covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), and the Rest of the World. Asia-Pacific is estimated to exhibit a significant growth rate in the global cluster headache market during the forecast period. The increasing geriatric population in the region drives the growth of the market. In addition, improving healthcare infrastructure further gives a boost to the regional growth of the market.

Moreover, the study of the global cluster headache market report covers the analysis of various players operating in the market. Some of the key players covered in the report include Eli Lilly and Co., Novartis International AG, AstraZeneca PLC, Pfizer Inc., GlaxoSmithKline PLC, and others. The market players are considerably contributing to market growth by adopting various organic and inorganic strategies to stay competitive in the market.

Research Methodology

The market study of the global cluster headache market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook.

In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for drug manufacturers, pharmaceutical companies, research organizations, academic institutes, government organizations, regulatory bodies, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, products offered by the companies, and future growth opportunities. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation:

1. Global Cluster Headache Market Research and Analysis by Type
2. Global Cluster Headache Market Research and Analysis by Drug Type

The Report Covers
  • Comprehensive research methodology of the global cluster headache market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global cluster headache market.
  • Insights about market determinants which are stimulating the global cluster headache market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Competitive Dashboard
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Eli Lilly and Co. Overview Financial Analysis SWOT Analysis Recent Developments
3.3.2. Novartis International AG Overview Financial Analysis SWOT Analysis Recent Developments
3.3.3. AstraZeneca PLC Overview Financial Analysis SWOT Analysis Recent Developments
3.3.4. Pfizer Inc. Overview Financial Analysis SWOT Analysis Recent Developments
3.3.5. GlaxoSmithKline PLC Overview Financial Analysis SWOT Analysis Recent Developments
4. Market Determinants
4.1 Motivators
4.2 Restraints
4.1. Opportunities
5. Market Segmentation
5.1. Global Cluster Headache Market by Types
5.1.1. Episodic
5.1.2. Chronic
5.2. Global Cluster Headache Market by Drug Type
5.2.1. Fast-Acting Drugs
5.2.2. Long-Term Drugs
5.2.3. Short-Term Drugs
6. Regional Analysis
6.1. North America
6.1.1. US
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. Allergan PLC
7.2. Allodynic Therapeutics, LLC
7.3. Amgen Inc.
7.4. AstraZeneca PLC
7.5. ElectroCore Medical LLC
7.6. Eli Lilly and Co.
7.7. Endo Pharmaceuticals Holdings Inc.
7.8. Fresenius Kabi AG
7.9. GlaxoSmithKline plc
7.10. Novartis International AG
7.11. Par Pharmaceutical
7.12. Pfizer Inc.
7.13. Sun Pharmaceutical Industries Ltd.
7.14. Teva Pharmaceutical Industries Ltd.
7.15. TrioxBio Inc.
7.16. Zogenix, Inc.
7.17. Zosano Pharma Corp.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Allergan PLC
  • Allodynic Therapeutics, LLC
  • Amgen Inc.
  • AstraZeneca PLC
  • ElectroCore Medical LLC
  • Eli Lilly and Co.
  • Endo Pharmaceuticals Holdings Inc.
  • Fresenius Kabi AG
  • GlaxoSmithKline plc
  • Novartis International AG
  • Par Pharmaceutical
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • TrioxBio Inc.
  • Zogenix, Inc.
  • Zosano Pharma Corp.